vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and ONESPAWORLD HOLDINGS Ltd (OSW). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $242.1M, roughly 1.1× ONESPAWORLD HOLDINGS Ltd). ONESPAWORLD HOLDINGS Ltd runs the higher net margin — 5.0% vs 0.7%, a 4.3% gap on every dollar of revenue. On growth, ONESPAWORLD HOLDINGS Ltd posted the faster year-over-year revenue change (11.5% vs -16.5%). ONESPAWORLD HOLDINGS Ltd produced more free cash flow last quarter ($14.9M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

HCM vs OSW — Head-to-Head

Bigger by revenue
HCM
HCM
1.1× larger
HCM
$270.8M
$242.1M
OSW
Growing faster (revenue YoY)
OSW
OSW
+28.0% gap
OSW
11.5%
-16.5%
HCM
Higher net margin
OSW
OSW
4.3% more per $
OSW
5.0%
0.7%
HCM
More free cash flow
OSW
OSW
$11.6M more FCF
OSW
$14.9M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
OSW
OSW
Revenue
$270.8M
$242.1M
Net Profit
$2.0M
$12.1M
Gross Margin
37.7%
Operating Margin
-13.2%
6.8%
Net Margin
0.7%
5.0%
Revenue YoY
-16.5%
11.5%
Net Profit YoY
-83.6%
-16.2%
EPS (diluted)
$0.00
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
OSW
OSW
Q4 25
$270.8M
$242.1M
Q3 25
$258.5M
Q2 25
$277.7M
$240.7M
Q1 25
$324.5M
$219.6M
Q4 24
$217.2M
Q3 24
$241.7M
Q2 24
$305.7M
$224.9M
Q1 24
$211.2M
Net Profit
HCM
HCM
OSW
OSW
Q4 25
$2.0M
$12.1M
Q3 25
$24.3M
Q2 25
$455.0M
$19.9M
Q1 25
$11.9M
$15.3M
Q4 24
$14.4M
Q3 24
$21.6M
Q2 24
$25.8M
$15.8M
Q1 24
$21.2M
Gross Margin
HCM
HCM
OSW
OSW
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Q1 24
Operating Margin
HCM
HCM
OSW
OSW
Q4 25
-13.2%
6.8%
Q3 25
10.2%
Q2 25
-1.3%
9.2%
Q1 25
-5.0%
7.7%
Q4 24
7.9%
Q3 24
10.3%
Q2 24
-9.0%
8.4%
Q1 24
8.0%
Net Margin
HCM
HCM
OSW
OSW
Q4 25
0.7%
5.0%
Q3 25
9.4%
Q2 25
163.8%
8.3%
Q1 25
3.7%
7.0%
Q4 24
6.6%
Q3 24
8.9%
Q2 24
8.4%
7.0%
Q1 24
10.0%
EPS (diluted)
HCM
HCM
OSW
OSW
Q4 25
$0.00
$0.12
Q3 25
$0.23
Q2 25
$0.52
$0.19
Q1 25
$0.01
$0.15
Q4 24
$0.13
Q3 24
$0.20
Q2 24
$0.03
$0.15
Q1 24
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
OSW
OSW
Cash + ST InvestmentsLiquidity on hand
$1.4B
$16.3M
Total DebtLower is stronger
$93.2M
$84.0M
Stockholders' EquityBook value
$1.2B
$542.6M
Total Assets
$1.8B
$707.1M
Debt / EquityLower = less leverage
0.08×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
OSW
OSW
Q4 25
$1.4B
$16.3M
Q3 25
$29.6M
Q2 25
$1.4B
$35.0M
Q1 25
$836.1M
$22.6M
Q4 24
$57.4M
Q3 24
$48.8M
Q2 24
$802.5M
$62.5M
Q1 24
$65.4M
Total Debt
HCM
HCM
OSW
OSW
Q4 25
$93.2M
$84.0M
Q3 25
$85.2M
Q2 25
$93.4M
$96.2M
Q1 25
$82.8M
$97.4M
Q4 24
$98.6M
Q3 24
$98.7M
Q2 24
$82.1M
$123.8M
Q1 24
$138.6M
Stockholders' Equity
HCM
HCM
OSW
OSW
Q4 25
$1.2B
$542.6M
Q3 25
$552.8M
Q2 25
$1.2B
$548.3M
Q1 25
$759.9M
$530.6M
Q4 24
$554.5M
Q3 24
$540.1M
Q2 24
$740.1M
$532.7M
Q1 24
$515.5M
Total Assets
HCM
HCM
OSW
OSW
Q4 25
$1.8B
$707.1M
Q3 25
$732.6M
Q2 25
$1.8B
$731.8M
Q1 25
$1.3B
$708.7M
Q4 24
$746.4M
Q3 24
$734.0M
Q2 24
$1.3B
$756.8M
Q1 24
$763.6M
Debt / Equity
HCM
HCM
OSW
OSW
Q4 25
0.08×
0.15×
Q3 25
0.15×
Q2 25
0.08×
0.18×
Q1 25
0.11×
0.18×
Q4 24
0.18×
Q3 24
0.18×
Q2 24
0.11×
0.23×
Q1 24
0.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
OSW
OSW
Operating Cash FlowLast quarter
$8.2M
$20.0M
Free Cash FlowOCF − Capex
$3.4M
$14.9M
FCF MarginFCF / Revenue
1.2%
6.2%
Capex IntensityCapex / Revenue
1.8%
2.1%
Cash ConversionOCF / Net Profit
4.21×
1.65×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$68.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
OSW
OSW
Q4 25
$8.2M
$20.0M
Q3 25
$33.2M
Q2 25
$-72.9M
$20.3M
Q1 25
$40.3M
$10.1M
Q4 24
$16.6M
Q3 24
$28.6M
Q2 24
$-39.8M
$18.7M
Q1 24
$15.0M
Free Cash Flow
HCM
HCM
OSW
OSW
Q4 25
$3.4M
$14.9M
Q3 25
$27.6M
Q2 25
$-82.2M
$17.6M
Q1 25
$32.5M
$8.4M
Q4 24
$13.2M
Q3 24
$27.5M
Q2 24
$-49.9M
$17.6M
Q1 24
$13.7M
FCF Margin
HCM
HCM
OSW
OSW
Q4 25
1.2%
6.2%
Q3 25
10.7%
Q2 25
-29.6%
7.3%
Q1 25
10.0%
3.8%
Q4 24
6.1%
Q3 24
11.4%
Q2 24
-16.3%
7.8%
Q1 24
6.5%
Capex Intensity
HCM
HCM
OSW
OSW
Q4 25
1.8%
2.1%
Q3 25
2.2%
Q2 25
3.3%
1.1%
Q1 25
2.4%
0.8%
Q4 24
1.5%
Q3 24
0.5%
Q2 24
3.3%
0.5%
Q1 24
0.6%
Cash Conversion
HCM
HCM
OSW
OSW
Q4 25
4.21×
1.65×
Q3 25
1.36×
Q2 25
-0.16×
1.02×
Q1 25
3.38×
0.66×
Q4 24
1.15×
Q3 24
1.33×
Q2 24
-1.54×
1.19×
Q1 24
0.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

OSW
OSW

Services$197.3M82%
Products$44.8M18%

Related Comparisons